Thymosin alpha 1 in the prevention of infected pancreatic necrosis following acute necrotising pancreatitis (TRACE trial): protocol of a multicentre, randomised, double-blind, placebo-controlled, parallel-group trial

INTRODUCTION: Infected pancreatic necrosis (IPN) and its related septic complications are the major causes of death in patients with acute necrotising pancreatitis (ANP). Therefore, the prevention of IPN is of great clinical value, and immunomodulatory therapy with thymosin alpha 1 may be beneficial...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jing, Mao, Wenjian, Ke, Lu, Chen, Tao, He, Wenhua, Pan, Xinting, Chen, Miao, He, Chengjian, Gu, Weili, Wu, Jingyi, Song, Jingchun, Ni, Haibin, Tu, Jianfeng, Sun, Junli, Zhang, Guoxiu, Chen, Weiwei, Xue, Bing, Zhao, Xiangyang, Shao, Min, Liu, Yuxiu, Tong, Zhihui, Li, Weiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526289/
https://www.ncbi.nlm.nih.gov/pubmed/32994239
http://dx.doi.org/10.1136/bmjopen-2020-037231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526289/
https://www.ncbi.nlm.nih.gov/pubmed/32994239
http://dx.doi.org/10.1136/bmjopen-2020-037231

Ejemplares similares